Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Goeltz II Robert C. Insider Profile
4 Followers
Goeltz II Robert C., Chief Financial Officer at CytomX Therapeutics, holds 63.44K shares in Arcus Biosciences (Ticker: RCUS), holds 161.03K shares in Unity Biotechnology (Ticker: UBX), holds 6.00K shares in CytomX Therapeutics (Ticker: CTMX).
Goeltz II Robert C. CytomX Therapeutics (CTMX)Chief Financial Officer
CytomX Therapeutics (CTMX)
Chief Financial Officer
Ranked #3,828 out of 102,868 Corporate Insiders
Profitable Transactions
8 out of 9 Profitable Transactions
Average Return
+48.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Goeltz II Robert C. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 09, 2017 - Mar 09, 2018
Return:+156.10%
The most profitable trade made by Goeltz II Robert C.
Goeltz II Robert C.'s Trading History
CytomX Therapeutics
May 16, 2017
Chief Financial Officer
Informative Buy
$110.62K
$11.16K
Unity Biotechnology
Jun 24, 2020
CFO
Uninformative Sell
$24.01K
$608.68K
Arcus Biosciences
Jan 25, 2023
CFO
Uninformative Buy
―
$1.04M
List of latest transactions for each holding click on a transaction to see Goeltz II Robert C.'s performance on stock
You May Also Like
Goeltz II Robert C. insider profile FAQ
What is the percentage of profitable transactions made by Goeltz II Robert C.?
The percentage of profitable transactions made by Goeltz II Robert C. is 89%.
What is the average return per transaction made by Goeltz II Robert C.?
The average return per transaction made by Goeltz II Robert C. is 48.00%.
What stocks does Goeltz II Robert C. hold?
Goeltz II Robert C. holds: CTMX, UBX, RCUS stocks.
What was Goeltz II Robert C.’s latest transaction?
Goeltz II Robert C. latest transaction was an Uninformative Buy of ―.
What was Goeltz II Robert C.'s most profitable transaction?
Goeltz II Robert C.’s most profitable transaction was an Informative Buy of CTMX stock on March 9, 2017. The return on the trade was 156.10%.
What is Goeltz II Robert C.'s role in CytomX Therapeutics?
Goeltz II Robert C.'s role in CytomX Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.